BioSpace News Archive

Press Releases

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 13, 2024

December 16, 2024
·
3 min read
Press Releases

Innoviva Specialty Therapeutics Signs Exclusive Distribution and Licensing Agreement to Acquire U.S. Marketing Rights for Zevtera® (ceftobiprole)

December 16, 2024
·
6 min read
Press Releases

VectorY Strengthens Leadership Team with Appointment of Jim Scibetta as New CEO

December 16, 2024
·
5 min read
Press Releases

KalVista Appoints Jeb Ledell as Chief Operating Officer

December 16, 2024
·
4 min read
Press Releases

SciSparc Provides Updates on Status of Spin-off of its Advanced Clinical Stage Pharmaceutical Portfolio to a Publicly Traded Company

December 16, 2024
·
4 min read
Press Releases

Annexon Announces Positive Topline Results from Real-World Evidence Study Comparing ANX005 Treatment to Intravenous Immunoglobulin (IVIg) or Plasma Exchange (PE) in a Matched Patient Cohort for the Treatment of Guillain-Barré Syndrome (GBS)

December 16, 2024
·
12 min read
Press Releases

Soligenix Initiates Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma

December 16, 2024
·
16 min read
Press Releases

Oragenics, Inc. Announces Conversion of Preferred Shares and Elimination of Liquidation Preference

December 16, 2024
·
2 min read
Press Releases

Emergent BioSolutions Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)

December 16, 2024
·
5 min read
Press Releases

Novotech Named a Fierce CRO Award Winner in the Excellence in Clinical Trial Management and Global Operations Categories

December 16, 2024
·
2 min read